HR ECHO | April 4 | The Use of Off-Label Medication for Substance Use Disorders

Carlos F. Tirado, MD, Founder and CEO of CARMAhealth, explains the current regulations related to the use of prescription opioids for the treatment of opioid use disorder. He discusses the evidence base for non-FDA approved medications for substance use disorders and how to apply clinical evidence for their off-label use in treating SUD.

For more videos in this ECHO series: Harm Reduction ECHO

To find out more about the Center for Substance Use Training and Telementoring (c-STAT): https://c-stat.uthscsa.edu/